Back to Atlas
CTransientStandard research/education caution
CMP-0421
Investigational/discontinued
Pipendoxifene / ERA-923
Endocrine / SERM
Breast cancer endocrine research positioning
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- SERM
- Primary mechanism
- Estrogen receptor modulation
- Primary market use
- Oncology / endocrine research
Pharmacology
- Molecular weight (Da)
- Not consistently disclosed
- Oral bioavailability
- Oral investigational
- Half-life
- Not consistently disclosed
- Route tags
- Route-dependent / verify
- Evidence level
- Clinical/Historical
- Clinical status
- Investigational/discontinued
- Value-for-money score
- 2 / 10
Reported protocol signal
No popular protocol verified yet; keep as reference compound until protocol signal is added.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
Developmental SERM with limited public PK